Brandon D. Jeffy, PhD, DABT

Senior Director
Crinetics Pharmaceuticals
San Diego, California, United States

Presentation(s):

• Addressing the Challenge of Drug-Induced Kidney Injury (DIKI) within Preclinical Drug Development (S01)

  Monday, November 18, 2024
  9:00 AM - 12:00 PM CT

• Discovery Toxicology Approaches to Assessment of Drug-Induced Kidney Injury (S01-5)

  Monday, November 18, 2024
  11:15 AM - 11:45 AM CT

• Targeted Protein Degrader Therapeutics: Opportunities and Challenges (S16)

  Wednesday, November 20, 2024
  9:00 AM - 12:00 PM CT

• Strategies for Assessing Targeted Protein Degrader Modality Safety in Drug Discovery Programs (S16-4)

  Wednesday, November 20, 2024
  9:50 AM - 10:15 AM CT